SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10045biz.yahoo.com IBD article on BIIB/Elan and Tysabri........much hope but still qArthur Radley-11/13/2008
10044>>1 case in monotherapy WITHOUT prior recent history of strong immunosupprBiomaven111/5/2008
10043Peter - drug holiday bandied about on the IV board. That board has lots of cluttSidney Street111/5/2008
10042We need to bear in mind that hypersensitivity and neutralizing antibodies have bidos311/5/2008
10041Has anyone discussed the concept of a drug holiday? Something like 6 months onBiomaven111/4/2008
10040Thanks Idos...eomfred hayes-11/3/2008
10039The TOUCH and TYGRIS programs along with docs&patients high awareness of sigidos411/2/2008
10038Merrill (BIIB oriented) <i>BIIB to face headwinds from first U.S. Tysabrtom pope-10/31/2008
10037deletedIRWIN JAMES FRANKEL-10/31/2008
10036Idos, is it reasonable to hope that there will be better risk management as we gfred hayes-10/31/2008
10035Estimation is that up to 80% of the world’s population is infected with latent Jidos-10/31/2008
10034Is there information on PML incidence in the non-MS population, or is it insignitom pope-10/31/2008
10033Clearly, the longterm PML/Tysabri association is not yet known so we're talkidos-10/31/2008
10032Too early in the re-treatment paradigm to call a rate for PML risk. We have notBiotech Jim-10/30/2008
10031On MS more generally: mednews.wustl.edu Medical News Releases > Medical NeIRWIN JAMES FRANKEL110/30/2008
10030I think that as long as the rate remains less than 1/1,000, risk/benefit will bidos-10/30/2008
10029I have to think the rate is going to creep up over time. At what rate would therkrw-10/30/2008
10028Demmitall, pouncing on ELN after the first panic woosh down would have been a grtom pope-10/30/2008
10027>My intuitive reaction is that we are still well below the label< Rate isidos-10/30/2008
10026I haven't decided yet. You might want to listen to Elan's last earnings Qualified Opinion-10/30/2008
10025The question should have been, "Has there ever been a biotech that has loststeve kammerer310/29/2008
10024Down 85% as a rhetorical question when people have lost a lot of money probably rkrw110/29/2008
10023Since the last two cases were disclosed we've had about 3,000 patients on thArthur Radley-10/29/2008
10022>> I come from a family of lawyers, but I never wanted to be one myself. IRWIN JAMES FRANKEL310/29/2008
10021<i>you missed your calling. You should have been a lawyer.</i> I coDewDiligence_on_SI110/29/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News